Photodegradation kinetics of Bilastine in tablets [PDF]
Drug Analytical ResearchPhotodegradation is the process by which a chemical substance is broken down through exposure to light, typically ultraviolet (UV) radiation. This process is significant in environmental chemistry, where sunlight can degrade pollutants and materials ...
Ariele Nunes Machado +6 more
doaj +9 more sources
Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study [PDF]
Drugs in ContextBackground: Second-generation oral H1-antihistamines, including bilastine, represent the emerging treatments of allergic rhinitis (including rhinoconjunctivitis) and chronic urticaria in both adults and children.
Giorgio Walter Canonica +7 more
doaj +3 more sources
Modulation of Bilastine Crystallinity for Enhanced Dissolution and Oral Bioavailability [PDF]
Pharmaceutical SciencesBackground: Bilastine is a second-generation antihistamine belonging to poorly soluble, highly permeable drug class. This resulted in low and variable oral bioavailability. Being antihistaminic, its combination with caffeine is possible. Accordingly, the
Zeinab M. Elrefaey +4 more
doaj +2 more sources
UV SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF BILASTINE USING EXPERIMENTAL DESIGN FOR ROBUSTNESS [PDF]
Drug Analytical Research, 2017 Bilastine is a novel nonsedative H1-receptor antagonist, which may be used for the symptomatic treatment of chronic idiopathic urticaria (CU). This study describes the validation of an UV spectrophotometric method for quantitative determination of ...
Andressa Tassinari da Silva +5 more
doaj +10 more sources
Bilastine: a lifetime companion for the treatment of allergies [PDF]
Current Medical Research and Opinion, 2019 Objective: Bilastine is a potent and highly selective H1-antihistamine approved for the treatment of allergic rhinoconjunctivitis and urticaria. This article summarizes available data on the use of bilastine in the treatment of allergic disorders in different age groups, including younger and older adults, and school-age children and adolescents ...
Church, Martin K +3 more
core +8 more sources
Bilastine: new insight into antihistamine treatment [PDF]
Clinical and Molecular Allergy, 2015 Bilastine is a new second generation H1-antihistamine recently approved for the symptomatic treatment of allergic rhinitis (AR) and chronic urticaria (CU). Bilastine epitomizes the evolution of research on antihistamines concerning both efficacy and safety.
RIDOLO, Erminia +4 more
openaire +6 more sources
Drugs in Context, 2017 Background: Bilastine is a safe and effective commonly prescribed non-sedating H1-antihistamine approved for symptomatic treatment in patients with allergic disorders such as rhinoconjunctivitis and urticaria. It was evaluated in many patients throughout
Amalia Leceta +4 more
doaj +2 more sources
Design, Optimization and Characterization of Self-Nanoemulsifying Drug Delivery Systems of Bilastine [PDF]
Iraqi Journal of Pharmaceutical Sciences, 2023 Self-nanoemulsifying drug delivery systems are innovative methods that have the potential to resolve a variety of drug formulation issues, including solubility, stability and bioavailability.
Ishraq Kadhim Abbas +1 more
doaj +2 more sources
A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria [PDF]
Indian Journal of DermatologyIntroduction: Chronic spontaneous urticaria (CSU) is the most commonly diagnosed skin condition in dermatology outpatient departments. Second-generation antihistamines are shown to be effective in the control of CSU.
Boggarapu Sneha +3 more
doaj +2 more sources
Drugs in Context, 2022 Urticaria is a disabling condition, resulting in an impaired quality of life and sleep disruption, and can have an adverse impact on work-related or school-related performance and attendance.
Wai Kwong Cheong +9 more
doaj +3 more sources